Pharmacokinetic studies in patients

9 Jan 2023

In this white paper, QPS describes why there is both a scientific and an ethical imperative to ensure PK studies are designed such that they provide useable results.

QPS Clinical Phase I/IIa Development Services

QPS

Moving quickly and safely through Phase I/IIa trials is critical to successful drug development.  The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually. 

(0)

Links

Tags

Pharmacokinetic studies in patients